Application of phytobacterium plantarum KSFY16 in preparation of medicine or food for improving weight loss caused by CUMS
By using the KSFY16 planta plantarum KSFY16 isolated from naturally fermented yak yogurt in Kashgar, Xinjiang, the weight loss in mice caused by CUMS was significantly improved, and the problem of insufficient fluoxetine replacement drugs in the prior art was solved, and significant results were achieved Effectiveness of improving weight problems caused by CUMS.
Patent Information
- Application Number
- CN202411135702.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
In existing studies, there is a deficit in finding alternative drugs or foods for fluoxetine to improve weight loss caused by chronic unpredictable mild stress (CUMS), especially in animal models that simulate long-term chronic stress.
Lactiplantibacillus plantarum KSFY16 (LP-KSFY16) was used to significantly improve mice caused by CUMS by the Collaborative Innovation Center for Children's Nutrition and Healthy Development. The weight loss showed an effective effect of maintaining the normal weight of mice and was similar to that of the fluoxetine group.
The LP-KSFY16 intervention significantly improved the weight loss in mice caused by CUMS, especially in the high concentration group, which showed better effects than the low concentration group, and did not significantly different from the fluoxetine group, indicating that it was improving the weight loss caused by CUMS. It has a significant improvement effect on weight issues.
Smart Images

Figure CN118948903A_ABST
Abstract
Description
Technical Field
[0001] The invention provides an application of Lactobacillus plantarum KSFY16 in preparing a medicine or food for improving weight loss caused by CUMS, belonging to the technical field of biomedicine. Background Art
[0002] Chronic unpredictable mild stress (CUMS) is a stress model commonly used in animal research. It simulates a long-term chronic stress state by applying a variety of unpredictable mild stress stimuli to animals. This model can highly simulate the stress and challenges in real life and has been paid attention to by more and more scientists.
[0003] Existing studies have found that the weight gain rate of mice decreases after CUMS induction, but after intervention with fluoxetine, the weight gain rate of mice recovers. Finding a drug or food to replace fluoxetine to improve the weight loss caused by CUMS is the problem to be solved by the present invention. Summary of the invention
[0004] In view of this, the object of the present invention is to provide an application of Lactobacillus plantarum KSFY16 in the preparation of a drug or food for improving weight loss caused by CUMS. The Lactobacillus plantarum KSFY16 (LP-KSFY16) of the present invention is separated from naturally fermented yak yogurt in Kashgar, Xinjiang by the Collaborative Innovation Center for Children's Nutrition and Healthy Development. It is currently preserved in the China General Microbiological Culture Collection Center with a preservation number of CGMCCNO.30929.
[0005] The weight gain rate of mice decreased after CUMS induction, and after intervention with fluoxetine and LP-KSFY16, the weight gain rate of mice recovered compared with the model group, wherein the high-concentration LP-KSFY16 group showed an effective effect of maintaining normal weight of mice, and its effect was better than the low-concentration LP-KSFY16 group (P<0.05) and similar to the fluoxetine group (P>0.05). This shows that Lactobacillus plantarum KSFY16 intervention in the experiment can significantly improve the weight loss of mice caused by CUMS. BRIEF DESCRIPTION OF THE DRAWINGS
[0006] Figure 1 The effect of LP-KSFY16 on the body weight changes of mice;
[0007] Figure 2 The effect of LP-KSFY16 on open field behavior of mice;
[0008] Figure 3The effect of LP-KSFY16 on the tail suspension behavior of mice;
[0009] Figure 4 The effect of LP-KSFY16 on the concentrations of 5-HT, ACTH, and IL-6 in the prefrontal cortex of mice;
[0010] Figure 5 This is the effect of LP-KSFY16 on the relative expression levels of mTOR, mTORC1, AKT, SIRT1, SIRT3 and PGC-1α mRNA in the cerebral cortex of mice. DETAILED DESCRIPTION
[0011] In order to make the purpose, technical scheme and advantages of the present invention clearer, the preferred embodiments of the present invention are further described in detail in conjunction with the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0012] 1 Materials and reagents
[0013] Experimental strain: Lactiplantibacillus plantarum KSFY16 (LP-KSFY16) was isolated from naturally fermented yak yogurt in Kashgar, Xinjiang by the Collaborative Innovation Center for Children's Nutrition and Healthy Development. It is currently preserved in the China General Microbiological Culture Collection Center with the preservation number CGMCC NO.30929, the preservation date is June 11, 2024, and the preservation address is No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0014] Table 1 Experimental materials and reagents
[0015]
[0016]
[0017] 2. Instruments and Equipment
[0018] Table 2 Instruments and equipment
[0019]
[0020]
[0021] 3 Experimental methods
[0022] 3.1 Animal Experiment Design
[0023] Fifty 6-week-old (20±1g) SPF male C57BL / 6 mice were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd. [Animal Qualification License No.: SCXK (Xiang) 2019–0004] and kept in a constant temperature and humidity environment with a temperature of 25±2℃ and a humidity of 50±5%. The mice were fed and drunk freely every 12h. All animal experiments were carried out in strict accordance with the laboratory animal use regulations and animal ethics experimental requirements. After 7 days of adaptive feeding, the mice were randomly divided into 5 groups, namely: normal group, fluoxetine group, positive control group, LP-KSFY16 low concentration group and LP-KSFY16 high concentration group. Except for the normal group, all mice in other groups were subjected to chronic unpredictable mild stimulation for 5 weeks, and the mice were gavaged or intraperitoneally injected every day. The normal group and the fluoxetine group were gavaged with 0.2 mL of sterile saline every day, the fluoxetine group was intraperitoneally injected with 0.1 mL of 10 mg / kg fluoxetine, and the low and high concentration LP-KSFY16 groups were gavaged with 1×10 7 CFU / kg and 1×10 9 CFU / kg of LP-KSFY16 live bacterial suspension was injected intraperitoneally with 0.1 mL of sterile saline. A one-week behavioral test began at week 6.
[0024] 3.2 CUMS modeling method
[0025] After one week of adaptive feeding of mice, the CUMS depression model was constructed to simulate various stress stimuli in human life. During the modeling process, the mice in the normal group were not given any stimulation and ate and drank water normally. The model group, fluoxetine group, LP-KSFY16 low concentration group and LP-KSFY16 high concentration group were given a random mild chronic stress stimulus once a day, and the same stimulus was not applied for three consecutive days. Each stress condition appeared randomly to avoid animal foresight. The specific CUMS implementation method is as follows:
[0026] (1) Tilted cage: Raise one end of the cage and tilt it 45° for 24 hours;
[0027] (2) Fasting: remove the mouse food for 24 h;
[0028] (3) Water deprivation + empty bottle stimulation: pour out the water in the water bottle and place the empty bottle in its original position for 24 hours;
[0029] (4) No bedding: remove the bedding from the cage for 8 h;
[0030] (5) Continuous illumination: The mice were exposed to continuous illumination for 24 h;
[0031] (6) Crowding stimulation: placing partitions in the mouse cage to reduce the activity area of the mice for 24 hours;
[0032] (7) Tail clamp: clamp the tail 1 cm away from the tip with hemostatic forceps for 60 seconds;
[0033] (8) Reversing the day and night cycle: Reversing the day and night cycle, the mouse cage was covered with a black cloth during the day, the black cloth was removed at 19:30, and the lights were turned on to simulate a bright light environment until 19:30 the next day;
[0034] (9) Restraint: mice were confined in a 50 mL plastic syringe for 2 h;
[0035] (10) Wet bedding: Sprinkle 200 mL of water into the bedding for 8 h.
[0036] The success of the modeling was analyzed and judged based on the results of subsequent behavioral experiments.
[0037] 3.3 Behavioral test - open field test
[0038] The open field test is used to evaluate the autonomous behavior, exploratory activities and tension of experimental animals in a novel environment. The mice were placed in the center of the open field device, and the time was immediately started and the whole process was recorded. The observation time was 6 minutes. After each experiment, the surroundings and the bottom should be wiped with alcohol to avoid residual animal information affecting the results. The video was digitally analyzed using AYN-mase 7.0 software to record the movement distance of the mice in the open field, the number of times the middle grid was crossed, and the time they stayed in the central area.
[0039] 3.4 Behavioral test - tail suspension test
[0040] The tail suspension test is used to evaluate the despair behavior of mice. The mouse's tail is fixed with tape at the back 1 / 3 and suspended 40 cm above the ground. The mouse is 15 cm away from the nearest object and is isolated from hearing and vision. Video recording software is used to record the video in time and stop recording after 6 minutes of observation. The software is used to analyze the immobility time of 3-6 minutes after tail suspension. The timing starts when the animal gives up active struggle and is completely immobile.
[0041] 3.5 Mouse dissection and sampling
[0042] After all behavioral tests were completed, the mice were fasted but not watered for 12 hours, and then all mice were euthanized and biological samples were collected. The mouse brains were carefully dissected on ice, placed in sterile centrifuge tubes, and stored at -80°C for later use.
[0043] 3.6 Determination of 5-HT, ACTH and IL-6 in the prefrontal cortex of mice
[0044] According to the instructions of the enzyme linked immunosorbent assay (ELISA) kit, the concentrations of 5-HT, ACTH and IL-6 in the mouse prefrontal cortex were measured.
[0045] 3.7 Determination of mTOR, mTORC1, AKT, SIRT1, SIRT3 and PGC-1α mRNA expression levels in mouse cerebral cortex
[0046] Weigh an appropriate amount of mouse cerebral cortex tissue, add TRIzol for homogenization to extract RNA from the tissue, and then use a spectrophotometer to measure the concentration and purity of the RNA extract, and reverse transcribe the RNA extract into cDNA according to the instructions of the reverse transcription kit. After reverse transcription, prepare the cDNA reaction system in an eight-tube strip, namely 10μL of Master mix, 1μL of upstream and downstream primers, 1μL of template cDNA, and 7μL of sterile enzyme-free water. The prepared reaction system was amplified and detected using real-time fluorescence quantitative PCR (Quantitative Real-time PCR, qPCR) technology. Amplification conditions: pre-denaturation at 95℃ for 5 min, then denaturation at 95℃ for 10 s, annealing at 60℃ for 30 s, and the whole process was repeated 40 times. After the determination, HprT was used as the internal reference gene and the formula 2 was used. -ΔΔCT Determine the relative expression of the target gene. The primer sequences used in this experiment are shown in Table 3.
[0047] Table 3 Primer sequences
[0048]
[0049] 3.8 Data processing and statistical analysis
[0050] All data were expressed as mean ± standard deviation (SD) and analyzed using IBM SPSS 23.0 statistical software. One-way analysis of variance (ANOVA) and Duncan's multiple range test were used for comparison between groups. The same lowercase letters in ae indicate no significant difference between the two groups, and different lowercase letters indicate significant difference between the two groups (P<0.05).
[0051] 4 Results and analysis
[0052] Effect of LP-KSFY16 on the body weight of CUMS mice
[0053] like Figure 1As shown in the figure, after the first week of adaptation, there was no significant difference in the weight of mice in each group, and the trend of weight growth was basically the same. Two weeks after induction, compared with the normal group, the weight growth rate of mice in the model group, fluoxetine group, LP-KSFY16 low concentration group and LP-KSFY16 high concentration group decreased, and the weight of each group began to differ. At the end of the 6th week of experimental modeling, the model group had the lightest weight, and the other four groups had significant differences (P<0.05). Among them, the weight of the LP-KSFY16 high concentration group was significantly heavier than that of the LP-KSFY16 low concentration group (P<0.05), and there was no significant difference between it and the fluoxetine group (P>0.05). The results showed that the weight gain rate of mice decreased after CUMS induction, but after intervention with fluoxetine and LP-KSFY16, the weight gain rate of mice recovered compared with the model group. The high-concentration LP-KSFY16 group showed an effective effect in maintaining the normal weight of mice, which was better than the low-concentration LP-KSFY16 group (P<0.05) and similar to the fluoxetine group (P>0.05). This shows that the intervention of Lactobacillus plantarum KSFY16 in the experiment can significantly improve the weight loss of mice caused by CUMS, but there is still a certain gap from the weight gain status of normal mice. 4.2 Effect of LP-KSFY16 on the behavior of CUMS mice
[0054] The open field test and tail suspension test were used to evaluate the anxiety and depression-like behaviors of mice. In the open field behavior test, the time spent in the center area and the frequency of entering the center area are indicators of the anxiety and depression behaviors of mice. Figure 2 As shown in A, compared with the normal group, the model group mice that were induced by CUMS without any intervention treatment had the shortest total crawling distance in the open field, the least number of crossing the middle grid, and the lowest percentage of staying in the middle grid. The experimental results of the fluoxetine group, the low-concentration LP-KSFY16 group, and the high-concentration LP-KSFY16 group were significantly higher than those of the model group, and there were significant differences between the groups (P<0.05). The overall trend showed that the fluoxetine group was better than the high-concentration LP-KSFY16 group, and the high-concentration LP-KSFY16 group was better than the low-concentration LP-KSFY16 group. It is worth mentioning that high-concentration LP-KSFY16 can significantly increase the total crawling distance of CUMS mice in the open field, and its effect is not significantly different from that of the fluoxetine group (P>0.05). Figure 2 B is a heat map of the behavioral trajectory of the open field experiment, which intuitively shows the movement trajectory of the experimental mice in the open field within 6 minutes. The results showed that CUMS induced a significant decrease in the activity of mice, which was significantly improved after intervention with fluoxetine and KSFY16, and the activity of mice tended to be normal, and the regulatory effect of high concentration of KSFY16 was significantly better than that of low concentration (P<0.05).
[0055] The tail suspension test reflects the desperate behavior of animals by analyzing the duration of the animal's struggle for survival and the duration of desperate immobility after the animal's body is inverted. Figure 3 As shown in the figure, compared with the normal group, the immobility time of the model group mice was significantly increased, indicating that the model group mice had strong despair and gave up struggling. After intervention with fluoxetine and LP-KSFY16, the immobility time, number of immobility times and percentage of immobility time of mice were significantly reduced (P<0.05), especially in the high-concentration LP-KSFY16 group, the immobility time of mice was significantly less than that of the low-concentration LP-KSFY16 group (P<0.05). At the same time, the trends of the number of immobility times and percentage of immobility time of tail suspension of mice were consistent with the immobility time of tail suspension of mice. It shows that the intervention of LP-KSFY16 can effectively alleviate the despair of CUMS mice.
[0056] Effects of LP-KSFY16 on 5-HT, ACTH and IL-6 levels in the prefrontal cortex of CUMS mice
[0057] like Figure 4 As shown in A, compared with the normal group, the 5-HT content in the prefrontal cortex of the model group mice affected by CUMS was significantly reduced (P<0.05). After intervention with fluoxetine and LP-KSFY16, the 5-HT concentration in the prefrontal cortex of mice was significantly increased on the basis of the model group (P<0.05), among which the 5-HT concentration in the high-concentration LP-KSFY16 group was significantly higher than that in the low-concentration LP-KSFY16 group (P<0.05), and there was no significant difference in the 5-HT content in the prefrontal cortex of mice treated with fluoxetine (P>0.05). At the same time, CUMS can cause a significant increase in the ACTH content in the prefrontal cortex of mice ( Figure 4 B), while the intervention of fluoxetine and LP-KSFY16 can significantly reduce the increase of ACTH caused by CUMS, among which the high-concentration LP-KSFY16 group has better effect than the low-concentration LP-KSFY16 group (P<0.05). In addition, IL-6 is a key pro-inflammatory cytokine and plays an important role in the regulation of inflammation and immunity. Figure 4 C shows that compared with the normal group, the IL-6 level in the prefrontal cortex of mice in the model group was the highest, indicating that CUMS can lead to an increase in the content of proinflammatory cytokines in mice. After intervention with fluoxetine and LP-KSFY16, the IL-6 concentration in the prefrontal cortex of mice was significantly reduced (P<0.05), indicating that fluoxetine and LP-KSFY16 both have a good effect in alleviating inflammation in mice, among which high concentration of LP-KSFY16 is better than low concentration.
[0058] 4.4 Effects of LP-KSFY16 on mTOR, mTORC1, AKT, SIRT1, SIRT3, and PGC-1α mRNA in the cerebral cortex of CUMS mice
[0059] like Figure 5 As shown in the data, compared with the normal group, CUMS caused a significant downregulation in the relative mRNA expression of mTOR, mTORC1, AKT, SIRT1, SIRT3 and PGC-1α in the cerebral cortex of mice (P<0.05), while after the intervention of fluoxetine and LP-KSFY16, their expression levels showed a significant upward trend (P<0.05), among which the effect of high concentration of LP-KSFY16 was significantly better than that of low concentration of LP-KSFY16 (P<0.05), and there was even no significant difference in the expression levels of mTOR and PGC-1α compared with the effect of the drug fluoxetine (P>0.05).
[0060] The present invention uses the CUMS method to construct a depression mouse model, and conducts a preliminary study on the effect and mechanism of Lactobacillus plantarum LP-KSFY16 in improving the depression-like behavior of mice induced by CUMS. The results show that the concentration of 1.0×10 9 CFU / kg of LP-KSFY16 gavage intervention can significantly reduce the anxiety, depression and despair behaviors of mice in the open field test and tail suspension test in behavioral tests; LP-KSFY16 intervention can significantly improve the symptoms of monoamine neurotransmitter disorders in chronic stressed mice, specifically manifested by the normalization of 5-HT and ACTH concentrations in the prefrontal cortex. It can also significantly upregulate the relative expression levels of mTOR, mTORC1, AKT, SIRT1, SIRT3 and PGC-1α mRNA. In summary, this study showed the significant effect of LP-KSFY16 in improving the depressive-like behavior of CUMS mice, revealing the specific mechanism of LP-KSFY16 in improving the depressive-like behavior of mice based on AKT / mTOR pathway-related genes. The results of this experiment provide a scientific basis for the intervention effect of LP-KSFY16 on depression and provide candidate strains for the development of functional foods to relieve depression.
[0061] The embodiments described above are part of the embodiments of the present invention, rather than all of the embodiments. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but merely represents selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
Claims
1. Application of Lactobacillus plantarum KSFY16 in the preparation of drugs or foods for improving weight loss caused by CUMS, It is characterized in that The Lactobacillus plantarum KSFY16 is deposited in the General Microbiology Center of China National Microbiological Culture Collection Administration, with the deposit number being CGMCC No.30929.
